Treatment of unprotected left main coronary artery disease with drug-eluting stents: is it time for a randomized trial?
Alaide Chieffo and Antonio Colombo*
Correspondence *EMO Centro Cuore Columbus, via M Buonarroti 48, 20145 Milan, Italy
Email colombo@emocolumbus.it
Revascularization is currently recommended for patients with unprotected left main coronary artery disease. In this review, Chieffo and Colombo discuss the safety and effectiveness of percutaneous interventions involving drug-eluting stents as an alternative approach for treating this disease.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$32 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
BRAVO I: A pilot study of vascular brachytherapy in polytetrafluoroethylene dialysis access graftsKidney International Original Article
BRAVO I: A pilot study of vascular brachytherapy in polytetrafluoroethylene dialysis access graftsKidney International Original Article
See all 18 matches for Research